0001127602-14-010742.txt : 20140307
0001127602-14-010742.hdr.sgml : 20140307
20140307171909
ACCESSION NUMBER: 0001127602-14-010742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140306
FILED AS OF DATE: 20140307
DATE AS OF CHANGE: 20140307
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 OAK PARK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-5000
MAIL ADDRESS:
STREET 1: 9 OAK PARK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wielinski Tracey Haas
CENTRAL INDEX KEY: 0001600891
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 14678310
MAIL ADDRESS:
STREET 1: C/O INSULET CORPORATION
STREET 2: 9 OAK PARK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-03-06
0001145197
INSULET CORP
PODD
0001600891
Wielinski Tracey Haas
C/O INSULET CORPORATION
9 OAK PARK DRIVE
BEDFORD
MA
01730
1
VP, Global Regulatory, CA, QA
Common Stock
2014-03-06
4
M
0
5000
23.27
A
32275
D
Common Stock
2014-03-06
4
S
0
7275
49.1021
D
25000
D
Common Stock
2014-03-06
4
S
0
1000
49.98
D
24000
D
Employee Stock Option (Right to Buy)
23.27
2014-03-06
4
M
0
5000
0
D
2023-02-01
Common Stock
5000
15000
D
Includes 15,000 restricted stock units granted on February 1, 2013, which vest one-third of the total units on February 1, 2015, one-third of the total units on February 1, 2016 and one-third of the total units on February 1, 2017, subject to continued employment; and 9,000 restricted stock units granted on March 3, 2014 which vest one-third of the total units on March 3, 2015, one-third of the total units on March 3, 2016, and one-third of the total units on March 3, 2017. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2013.
The price reported represents the weighted average sales price of the shares sold. The shares were sold at varying prices in the range of $48.60 to $49.64. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.
/s/ R. Anthony Diehl, attorney in fact
2014-03-07